Welcome to MyAge

MyAge is a national network of researchers taking an interdisciplinary approach to investigate muscle resilience across the life course: from cells to society


  • Funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) to run from February 2022 until 31 March 2025 for three years.
  • Tackling muscle loss in later life by promoting interdisciplinary collaboration among relevant research areas, across the UK.
  • Bringing together researchers, policy makers, industrialists, funders.
  • Working alongside people affected by muscle decline and younger people to understand how to address the complexity of the ageing processes, breakdown silos and promote new ways of thinking about old problems.

“The UKRI government funding body have set us a challenge to transform ageing research in the UK. Ageing is a ‘wicked’ problem which is best addressed through a collective effort – bringing different disciplines together – such as biology and social science. We’re also working alongside stakeholders within industry, policy and public contributors to help find ways to improve the health of older people, as well as reaching out and connecting with experts internationally.”

Professor Carolyn Greig, MyAge Co-Director

The MyAge Roadmap is the product of almost two years of collective work by network members. It aims to identify the most important knowledge gaps and best approaches for strengthening muscle resilience research across the life course. The Roadmap can be downloaded here.

Summary of the MyAge launch and gap analysis discussion by Jonny Glover, More Than Minutes, May 2022

MyAge Interdisciplinary Sandpit in June 2022. Discussions captured by Jonny Glover.

Physiology 23 Symposium: Skeletal Muscle Atrophy in Response to Disuse – discussions captured by Raquel Duran, More Than Minutes, July 2023

The MyAge Roadmap Launch, November 2023. Presentations and discussions captured by Jonny Glover.

Summary of the MyAge Roadmap, published 21 November 2023, by Jonny Glover.